jborza

Home>Admin

About Admin

This author has not yet filled in any details.
So far Admin has created 16 blog entries.
Sep 8 2020

Halberd Corporation Research on Covid-19 Treatment Development Begins at ASU

By |2020-09-08T11:19:17-04:00September 8th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 8, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced Arizona State University (ASU) commenced its research work for Halberd Corp. The initial phases of ASU’s research focuses on the development of antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications for extracorporeal removal of ...

Sep 2 2020

Why Halberd Corporation Selected ASU And Where They Stand Among Other Universities

By |2020-09-02T08:00:19-04:00September 2nd, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, September 2, 2020 – Halberd Corporation (OTC PINK: "HALB") today revealed why they selected Arizona State University (ASU) to conduct sponsored research to develop a Covid-19 treatment. ASU is one of the fastest growing research universities in the country and ranks among the top 10 for Department of Health and Human Services ...

Aug 31 2020

Halberd Selects Arizona State University (ASU) to Develop Its Patented Covid-19 Treatment(s)

By |2020-08-31T08:00:31-04:00August 31st, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 31, 2020 – Halberd Corporation (OTC PINK: "HALB") today announced the signing of a development agreement with Arizona State University (ASU) to conduct sponsored research to develop Halberd’s Covid-19 treatments.  The work will focus on developing antibodies in support of Halberd’s two issued patents and three Covid-19 related provisional patent applications ...

Aug 27 2020

Halberd Corporation Selects University Research Partner

By |2020-08-27T08:00:21-04:00August 27th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, August 27, 2020 – Halberd Corp. (OTC PINK: "HALB") is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd’s patented extracorporeal treatment of Covid-19.  Terms of the agreement have been finalized and ...

Aug 18 2020

Halberd Corporation CEO Answers Shareholders’ Questions Regarding Covid-19 Treatment

By |2020-08-18T08:00:11-04:00August 18th, 2020|Featured, Investor News, News, Technology|0 Comments

Jackson Center, PA, August 18, 2020 – Halberd Corp. (OTC PINK: "HALB") Chairman, President & CEO of Halberd Corporation, William A. Hartman, has received a number of questions from shareholders regarding the extracorporeal process for treatment of Covid-19. Below, Mr. Hartman responds to those questions. Q:  There are various extracorporeal medical procedures being researched or ...

Aug 10 2020

Halberd Corporation Adds Dr. Abdon Nanhay to Scientific Advisory Board

By |2020-08-10T08:00:04-04:00August 10th, 2020|Featured, Investor News, News|0 Comments

Furthering the Fight Against Covid-19 Internationally Jackson Center, PA, August 10, 2020 – Halberd Corp. (OTC PINK: "HALB") today confirmed the addition of Dr. Abdon Nanhay as a member of the Scientific Advisory Board.  Dr. Nanhay, a Brazilian physician, has over 25 years of experience in health and biological sciences. Dr. Nanhay’s experiences include general ...

Aug 4 2020

Halberd Corporation Secures $2 Million for Covid-19 Research

By |2020-08-04T08:00:29-04:00August 4th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, August 4, 2020 – Halberd Corp. (OTC PINK: "HALB") announced today that they have secured non-dilutive, grant-based funding for their patent pending Covid-19 treatment(s).  Newly formed Nonprofit Organization, Epidemiologic Solutions Corporation, a Louisiana, Internal Revenue Code Section 501(c)(3) application pending, has committed to provide funding of approximately $2,000,000, as required by Halberd ...

Jul 16 2020

Halberd Advances the Treatment of COVID-19 Utilizing Laser Technology

By |2020-07-21T11:29:21-04:00July 16th, 2020|Featured, Investor News|0 Comments

Jackson Center, PA, July 16, 2020 – Halberd Corp. (OTC PINK: "HALB") intends to use laser technology to eradicate the COVID-19 Coronavirus. This patent pending treatment introduces one or more fluorescent antibody-antigen complexing agents to bind with the target antigen(s) (i.e., Covid-19 target antigens). This will allow the virus to be seen and located, and ...

Jul 13 2020

Halberd Corp – Update July 13, 2020 – Addresses Certain Issues

By |2020-07-12T21:15:03-04:00July 13th, 2020|Featured, Investor News, News|0 Comments

Jackson Center, PA, July 13, 2020 – Halberd Corp. (OTC PINK: "HALB") today issued a statement to clarify certain items within its charter regarding allowable debt.  There have been inaccurate rumors that have put the company in a negative light.  One of these is that the company intends to take on convertible debt. Nothing could ...

Go to Top